Cargando…
EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma
BACKGROUND: As a member of the Ephrin protein family that elicits short distance cell‐cell signaling, EphrinA3 has been shown to promote or inhibit tumorigenesis depending on tumor types, but its roles and the underlying mechanisms in lung adenocarcinoma (LUAD) have not been reported. MATERIALS AND...
Autores principales: | Yiminniyaze, Ruzetuoheti, Zhang, Xiujuan, Zhu, Ning, Wang, Jing, Li, Chengwei, Wumaier, Gulinuer, Zhou, Daibing, Li, Jing, Xia, Jingwen, Zhang, Youzhi, Dong, Liang, Zhang, Yuanyuan, Li, Shengqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883548/ https://www.ncbi.nlm.nih.gov/pubmed/35770949 http://dx.doi.org/10.1002/cam4.4987 |
Ejemplares similares
-
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling
por: Wang, Jing, et al.
Publicado: (2022) -
Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells
por: Dong, Liang, et al.
Publicado: (2022) -
Diagnostic efficiency and safety of rapid on‐site evaluation combined with CT‐guided transthoracic core needle biopsy in suspected lung cancer patients
por: Yiminniyaze, Ruzetuoheti, et al.
Publicado: (2022) -
Identification and comparison of
Chlamydia psittaci
, Legionella and Mycoplasma pneumonia infection
por: Zhu, Ning, et al.
Publicado: (2023) -
Chemotherapy in combination with pembrolizumab and antiangiogenesis
in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two
case reports
por: Zhou, Daibing, et al.
Publicado: (2021)